Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Language
Publication year range
1.
J Med Life ; 17(1): 41-49, 2024 Jan.
Article in English | MEDLINE | ID: mdl-38737657

ABSTRACT

Multi-drug resistant (MDR) Enterobacterales remain a major clinical problem. Infections caused by carbapenem-resistant strains are particularly difficult to treat. This study aimed to assess the clinical and epidemiological characteristics of MDR Enterobacterales isolates. A total of 154 non-repetitive clinical isolates, including Escherichia coli (n = 66), Klebsiella pneumoniae (n = 70), and other Enterobacterales (n = 18), were collected from the Diagnostic Microbiology Laboratory at King Fahad Hospital of the University. Most E. coli isolates were collected from urine specimens (n = 50, 75.8%) and resistance against the third and fourth-generation cephalosporins (ceftriaxone, ceftazidime, cefixime, and cefepime) and fluoroquinolones (ciprofloxacin and levofloxacin) was assessed. Clonal relatedness analysis using enterobacterial repetitive intergenic consensus polymerase chain reaction (ERIC-PCR) revealed two clones (E. coli A and B), each comprising two strains. Most K. pneumoniae samples were collected from respiratory specimens (27.1%, 20 samples), and the strains showed overall resistance to most of the antimicrobials tested (54%‒100%). Moreover, clonal-relatedness analysis using ERIC-PCR revealed seven major clones of K. pneumoniae. These findings suggest nosocomial transmission among some identical strains and emphasize the importance of strict compliance with infection prevention and control policies and regulations. Environmental reservoirs could facilitate this indirect transmission, which needs to be investigated.


Subject(s)
Anti-Bacterial Agents , Drug Resistance, Multiple, Bacterial , Humans , Drug Resistance, Multiple, Bacterial/genetics , Saudi Arabia/epidemiology , Anti-Bacterial Agents/pharmacology , Anti-Bacterial Agents/therapeutic use , Microbial Sensitivity Tests , Male , Female , Enterobacteriaceae/drug effects , Enterobacteriaceae/isolation & purification , Enterobacteriaceae/genetics , Enterobacteriaceae Infections/epidemiology , Enterobacteriaceae Infections/microbiology , Enterobacteriaceae Infections/drug therapy , Klebsiella pneumoniae/drug effects , Klebsiella pneumoniae/isolation & purification , Klebsiella pneumoniae/genetics , Cross Infection/microbiology , Cross Infection/epidemiology , Cross Infection/drug therapy , Adult , Escherichia coli/drug effects , Escherichia coli/isolation & purification , Escherichia coli/genetics , Middle Aged , Hospitals, University
2.
Braz. j. microbiol ; 46(3): 641-647, July-Sept. 2015. tab, ilus
Article in English | LILACS | ID: lil-755830

ABSTRACT

Dormancy models for Mycobacterium tuberculosis play important roles in understanding various aspects of tuberculosis pathogenesis and in the testing of novel therapeutic regimens. By simulating the latent tuberculosis infection, in which the bacteria exist in a non-replicative state, the models demonstrate reduced susceptibility to antimycobacterial agents. This minireview outlines the models available for simulating latent tuberculosis both in vitro and in several animal species. Additionally, this minireview discusses the advantages and disadvantages of these models for investigating the bacterial subpopulations and susceptibilities to sterilization by various antituberculosis drugs.

.


Subject(s)
Animals , Guinea Pigs , Mice , Rabbits , Antitubercular Agents/pharmacology , Disease Models, Animal , Latent Tuberculosis/pathology , Mycobacterium tuberculosis/growth & development , Tuberculosis, Pulmonary/pathology , Drug Resistance, Bacterial , Indicators and Reagents/pharmacology , Latent Tuberculosis/drug therapy , Latent Tuberculosis/microbiology , Macaca fascicularis , Mycobacterium tuberculosis/drug effects , Mycobacterium tuberculosis/metabolism , Oxazines/pharmacology , Tuberculosis, Pulmonary/drug therapy , Tuberculosis, Pulmonary/microbiology , Xanthenes/pharmacology , Zebrafish
SELECTION OF CITATIONS
SEARCH DETAIL